Filing Details

Accession Number:
0001209191-20-065165
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-12-28 16:06:22
Reporting Period:
2020-12-23
Accepted Time:
2020-12-28 16:06:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1759425 Mirum Pharmaceuticals Inc. MIRM () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1614740 Christopher Peetz C/O Mirum Pharmaceuticals, Inc.
950 Tower Lane, Suite 1050
Foster City CA 94404
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-12-23 3,000 $18.76 199,570 No 4 P Indirect By The Peetz Family Trust
Common Stock Acquisiton 2020-12-23 2,000 $18.60 201,570 No 4 P Indirect By The Peetz Family Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By The Peetz Family Trust
No 4 P Indirect By The Peetz Family Trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,371 Direct